SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
347(Again FWIW) I now have a few ABGXnigel bates-3/1/2002
346And it's not getting any better today, Nigel, at least not yet. Both PDLI atom pope-3/1/2002
345<i>Up nearly 5%, Nigel. If you were to liquidate today...</i> Maybenigel bates-3/1/2002
344Additional information MorphoSys / Xoma deal. Money flow from MorphoSys to Xomaaknahow-2/25/2002
343MorphoSys and XOMA Cross-License Antibody Technologies MorphoSys Sole Licensee onigel bates-2/25/2002
342If only my own investments had done so well this year. In any event, we'renigel bates-2/21/2002
341Up nearly 5%, Nigel. If you were to liquidate today you'd probably wind up wtom pope-2/21/2002
340Genmab's HuMax-CD4 Awarded Fast Track Status From FDA COPENHAGEN, Denmark, nigel bates-2/21/2002
339I've no intention of managing a thread portfolio (for now, anyway), but currnigel bates-2/20/2002
338SAN CARLOS, Calif.--(BW HealthWire)--Feb. 19, 2002--Neugenesis Corporation announigel bates-2/19/2002
337Biosite(R) Incorporated Announces Implementation of New Antibody Expression Technigel bates-2/14/2002
336SANTA CLARA, Calif., Feb. 13 /PRNewswire/ -- Genetastix, a privately held biotecnigel bates-2/13/2002
335SAN DIEGO, Feb. 13 /PRNewswire/ -- The world antibody business development and inigel bates-2/13/2002
334Interesting link, with lots of stuff - healthtech.com (thanks Mike.) (for exanigel bates-2/13/2002
333Another 'directed evolution' company getting involved in antibodies... nigel bates-2/6/2002
332One would not know in general, only if drug's sponsor disclosed it. Yet I tkeokalani'nui-2/3/2002
331<i>how would one know that phage display technology had played a part in tnigel bates-2/3/2002
330Thanks. In general how would one know that phage display technology had played aknahow-2/3/2002
329>>Any products actually on the market that involved phage display in theirkeokalani'nui-2/3/2002
328Any products actually on the market that involved phage display in their developaknahow-2/2/2002
327Biovation Ltd. Now Represented by its Own Office in the U.S. DARMSTADT, Germanynigel bates-1/30/2002
326Good time to settle this thing. EOM.keokalani'nui-1/28/2002
325U.S. Court Grants Favorable Orders to MorphoSys in CAT Patent Disputes MARTINSRnigel bates-1/28/2002
324Some news from our southern neighbors (i.e. from Danish Genmab). 1. New appointIcebrg-1/27/2002
323One for Tuck ? <g> SAN DIEGO, Jan. 23 /PRNewswire/ -- The world antibody nigel bates-1/23/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News